MMSET inhibitor

· K36 Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MMSET inhibitor, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma [Phase 1]